Lyora Therapeutics, Inc. — Form D
Lyora Therapeutics, Inc. of BELMONT, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-11. The offering totals $2.0M, of which $525K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-11
- Form: D
- Accession: 0002058969-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $525K
- Remaining: $1.5M
- Investors: 4
- Date of first sale: 2025-02-25
- Revenue range: Decline to Disclose
- SEC file number: 021-540370
Issuer
- Name: Lyora Therapeutics, Inc.
- CIK: 0002058969
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 118 GODEN STREET, BELMONT, MA, 02478
- Phone: 2157764288
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Eric Pierce, MD, PhD | Director | Belmont, MA |
| Luc Vandenberghe, PhD | Director | Belmont, MA |
| Luc Vandenberghe, PhD | Executive Officer | Belmont, MA |
More